Abstract
The serotonin (5-hydroxtryptamine, 5-HT) system plays a role in analgesia and emesis. The aim of this study was to test whether opioids or ketamine inhibit the human 5-HT transporter and whether this increases free plasma 5-HT concentrations. HEK293 cells, stably transfected with the human 5-HT transporter cDNA, were incubated with morphine, hydromorphone, fentanyl, alfentanil, pethidine (meperidine), tramadol, ketamine, and the reference substance citalopram (specific 5-HT transporter inhibitor). The uptake of [3H]5-HT was measured by liquid scintillation counting. In a second series of experiments, study drugs were incubated with plasma of ten healthy blood donors and change of 5-HT plasma-concentrations were measured (ELISA). The end point was the inhibition of the 5-HT transporter by different analgesics either in HEK293 cells or in human platelets ex vivo. Tramadol, pethidine, and ketamine suppressed [3H]5-HT uptake dose-dependently with an IC50 of 1, 20.9, and 230 μM, respectively. These drugs also prevented 5-HT uptake in platelets with an increase in free plasma 5-HT. Free 5-HT concentrations in human plasma were increased by citalopram 1 μM, tramadol 20 μM, pethidine 30 μM, and ketamine 100 μM to 280 [248/312]%, 269 [188/349]%, and 149 [122/174]%, respectively, compared to controls without any co-incubation (means [95 % CI]; all p < 0.005). No change in both experimental settings was observed for the other opioids. Tramadol and pethidine inhibited the 5-HT transporter in HEK293 cells and platelets. This inhibition may contribute to serotonergic effects when these opioids are given in combination, e.g., with monoamine oxidase inhibitors or selective serotonin reuptake inhibitors.
Similar content being viewed by others
References
Ailawadhi S, Sung KW, Carlson LA, Baer MR (2007) Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther 32:199–202. doi:10.1111/j.1365-2710.2007.00813.x
Alkhatib AA, Peterson KA, Tuteja AK (2010) Serotonin syndrome as a complication of fentanyl sedation during esophagogastroduodenoscopy. Dig Dis Sci 55:215–216. doi:10.1007/s10620-009-0711-x
Barann M, Meder W, Dorner Z, Brüss M, Bönisch H, Göthert M, Urban BW (2000) Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects. Naunyn Schmiedebergs Arch Pharmacol 362:255–265
Barann M, Brüss M, Brinkmann M, Linden I, Lyutenska M, Schneider M, Walkembach J, Wittmann M (2006a) 5-HT3 receptors and emesis. Pharmacol Rep 58:253–255
Barann M, Urban B, Stamer U, Dorner Z, Bönisch H, Brüss M (2006b) Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis. Eur J Pharmacol 531:54–58. doi:10.1016/j.ejphar.2005.11.054
Bijl D (2004) The serotonin syndrome. Neth J Med 62:309–313
Boyer EW, Shannon M (2005) The serotonin syndrome. N Engl J Med 352:1112–1120. doi:10.1056/NEJMra041867
Chen C, Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745–2752. doi:10.1128/MCB.7.8.2745
Fisar Z, Hroudová J, Raboch J (2010) Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers. Neuro Endocrinol Lett 31:645–656
Gillman PK (2005) Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth 95:434–441. doi:10.1093/bja/aei210
Gillman PK. (2014) Monoamine oxydase inhibitors, opiate analgesics and serotonin toxicity. Available: http://www.psychotropical.com/index.php/moi-oa-st. Accessed 30 March 2014. doi 10.1093/bja/aei210. PMID: 16051647
Gollapudy S, Kumar V, Dhamee MS (2012) A case of serotonin syndrome precipitated by fentanyl and ondansetron in a patient receiving paroxetine, duloxetine, and bupropion. J Clin Anesth 24:251–252. doi:10.1016/j.jclinane.2011.04.017
Grond S, Meuser T, Uragg H, Stahlberg HJ, Lehmann KA (1999) Serum concentrations of tramadol enantiomers during patient-controlled analgesia. Br J Clin Pharmacol 48:254–257. doi:10.1046/j.1365-2125.1999.00986.x
Jeleazcov C, Saari TI, Ihmsen H, Mell J, Fröhlich K, Krajinovic L, Fechner J, Schüttler J (2012) Population pharmacokinetic modeling of hydromorphone in cardiac surgery patients during postoperative pain therapy. Anesthesiology 120:378–391. doi:10.1097/ALN.0b013e3182a76d05
Jellinek H, Haumer H, Grubhofer G, Klappacher G, Jenny T, Weindlmayr-Goettel M, Fitzal S (1990) Tramadol in postoperative pain therapy. Patient-controlled analgesia versus continuous infusion. Anaesthesist 39:513–520
Koska AJ, Kramer WG, Romagnoli A, Keats AS, Sabawala PB (1981) Pharmacokinetics of high-dose meperidine in surgical patients. Anesth Analg 60:8–11
Lehmann KA, Kratzenberg TP, Schroeder-Bark B, Horrichs-Haermeyer G (1990) Postoperative patient-controlled analgesia with tramadol. Analgesic efficacy and minimum effective concentrations. Clin J Pain 6:212–220
Millan MJ (2002) Descending control of pain. Prog Neurobiol 66:355–474. doi:10.1016/S0301-0082(02)00009-6
Niesler B, Frank B, Kapeller J, Rappold GA (2003) Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene 310:101–111. doi:10.1016/S0378-1119(03)00503-1
O’Sullivan JF (1962) Analgesia for forceps delivery. A technique for the “single-handed” obstetrician. Br Med J 1:151–152
Paech MJ, Moore JS, Evans SF (1994) Meperidine for patient-controlled analgesia after cesarean section. Intravenous versus epidural administration. Anesthesiology 80:1268–1276
Pedavally S, Fugate JE, Rabinstein AA (2014) Serotonin syndrome in the intensive care unit: clinical presentations and precipitating medications. Neurocrit Care 21:108–113. doi:10.1007/s12028-013-9914-2
Rang ST, Field J, Irving C (2008) Serotonin toxicity caused by an interaction between fentanyl and paroxetine. Can J Anaesth 55:521–625. doi:10.1007/BF03016672
Rastogi R, Swarm RA, Patel TA (2008) Case scenario: opioid association with serotonin syndrome: implications to the practitioners. Anesthesiology 115:1291–1298. doi:10.1097/ALN.0b013e31823940c0
Reves JG, Glas P, Lubarsky DA (2011) Nonbarbiturate intravenous anesthetics. In: Miller RD, Cuchiara RF, Miller ED, Reves JG, Roizen MF, Savarese JJ (eds) Anesthesia. Churchill Livingston, Philadelphia, pp 282–372
Schloss P, Williams DC (1998) The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol 12:115–121. doi:10.1177/026988119801200201
Sommer C (2006) Is serotonin hyperalgesic or analgesic? Curr Pain Headache Rep 10:101–106
Stamer UM, Musshoff F, Kobilay M, Madea B, Hoeft A, Stuber F (2007) Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes. Clin Pharmacol Ther 82:1–7. doi:10.1038/sj.clpt.6100152
Sun-Edelstein C, Tepper SJ, Shapiro R (2008) Drug-induced serotonin syndrome: a review. Expert Opin Drug Saf 7:87–96. doi:10.1517/14740338.7.5.587
Urban BW, Bleckwenn M, Barann M (2006) Interactions of anesthetics with their targets: non-specific, specific or both? Pharmacol Ther 111:729–770. doi:10.1016/j.pharmthera.2005.12.005
White PF, Way WL, Trevor AJ (1980) Pharmacology of ketamine isomers in surgical patients. Anesthesiology 52:231–239
Wittmann M, Peters I, Schaaf T, Wartenberg HC, Wirz S, Nadstawek J, Urban BW, Barann M (2006) The effects of morphine on human 5-HT3A receptors. Anesth Analg 103:747–752. doi:10.1213/01.ane.0000229706.84471.4d
Wittmann M, Schaaf T, Peters I, Wirz S, Urban BW, Barann M (2008) The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors. Anesth Analg 107:107–112. doi:10.1213/ane.0b013e31817342c2
Acknowledgements
This study was funded by a grant of the Deutsche Forschungsgemeinschaft (DFG; BA 1454).
We thank Gundula Hesse, Zita Dorner, and Caroline von dem Bussche for helpful technical assistance.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
M. Barann and U. M. Stamer, these authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Barann, M., Stamer, U.M., Lyutenska, M. et al. Effects of opioids on human serotonin transporters. Naunyn-Schmiedeberg's Arch Pharmacol 388, 43–49 (2015). https://doi.org/10.1007/s00210-014-1056-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-014-1056-3